Literature DB >> 27025075

[Prevention of dementia].

Katsuya Urakami.   

Abstract

The dementia prevention consists of three steps, primary prevention of dementia is to prevent from normal and mild cognitive impairment to dementia, secondary prevention is early detection and early treatment of dementia, and tertiary prevention is three stages of progress prevention of dementia. Primary prevention of dementia had been considered impossible until recently, but potential scientific evidence has been shown recently. The fact that 4.62 million people are person with dementia and 400 million people are person with mild cognitive impairment are considered to be urgent problem and we must intend to perform dementia prevention from primary to tertiary prevention thoroughly. We perform dementia screening using touch panel type computer and we recommend person with mild cognitive impairment to join dementia prevention classroom. Therefore, we can prevent progression from mild cognitive impairment to dementia (primary prevention). Early diagnosis and introduction to the specialized medical institution are needed if you find early stage of dementia and treat early (secondary prevention). To prevent progression by the appropriate drug treatment and care for dementia is required (tertiary prevention).

Entities:  

Mesh:

Year:  2016        PMID: 27025075

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

Review 1.  Dementia Prevention and Aromatherapy in Japan.

Authors:  Katsuya Urakami
Journal:  Yonago Acta Med       Date:  2022-08-01       Impact factor: 1.371

2.  Changes in Serum Amyloid A (SAA) and 8-OHdG in Patients with Senile Early Cognitive Impairment.

Authors:  Xiaohong Cao; Ping Chen
Journal:  Med Sci Monit       Date:  2020-02-01

3.  Kobe project for the exploration of newer strategies to reduce the social burden of dementia: a study protocol of cohort and intervention studies.

Authors:  Yoji Nagai; Shinsuke Kojima; Hisatomo Kowa; Yasuji Yamamoto; Hiroyuki Kajita; Tohmi Osaki; Yasumasa Kakei; Kavita U Kothari; Ryoma Kayano
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.